{
  "publication/title": "Machine Learning to Predict, Detect, and Intervene Older Adults Vulnerable for Adverse Drug Events in the Emergency Department",
  "publication/authors": "The authors who contributed to this article are:\n\n- Boyer, Edward\n- Ouchi, Katsuhide\n\nNot sure about the specific contributions of each author to the paper.",
  "publication/journal": "J. Med. Toxicol.",
  "publication/year": "2018",
  "publication/pmid": "29858745",
  "publication/pmcid": "PMC6097964",
  "publication/doi": "10.1186/s40360-017-0153-6",
  "publication/tags": "- Machine Learning\n- Adverse Drug Events\n- Electronic Health Records\n- Predictive Analytics\n- Natural Language Processing\n- Older Adults\n- Emergency Department\n- Toxicology\n- Big Data\n- Patient Safety",
  "dataset/provenance": "The dataset utilized in our study is derived from electronic health records (EHRs), which are comprehensive repositories of patient health information. These records include structured data such as diagnostic codes, laboratory results, and medication prescriptions, as well as unstructured data like physician notes and clinical narratives. The EHRs used in this research are from a nationally representative sample of Medicare fee-for-service beneficiaries, encompassing a vast number of data points. Specifically, a 5% sample of all Medicare beneficiaries was analyzed, which translates to approximately 2,000,000 individuals.\n\nThe structured data within the EHRs were augmented with markers of disease progression, such as the number of medical encounters, to enhance the predictive accuracy of our models. Additionally, unstructured text data from physician notes were leveraged using natural language processing (NLP) techniques to detect symptoms and other relevant clinical information that might indicate adverse drug events (ADEs).\n\nPrevious research has also utilized EHR data to predict health outcomes, including mortality and adverse drug events. For instance, random forest approaches have been employed to predict 6-month mortality in older adults with congestive heart failure, demonstrating the feasibility and effectiveness of using EHR data for such predictions. Furthermore, NLP has been used to analyze clinical notes for detecting patient-reported symptoms, showcasing its potential in identifying ADEs.\n\nThe integration of wearable biosensor data with EHR information represents a promising avenue for future research. Wearable devices can provide real-time physiological data, which, when combined with EHR records, can offer a more holistic view of a patient's health status. This integration can enhance the predictive strength of machine learning algorithms, enabling more accurate and timely interventions for ADEs.",
  "dataset/splits": "Not enough information is available.",
  "dataset/redundancy": "Not enough information is available.",
  "dataset/availability": "Not enough information is available.",
  "optimization/algorithm": "The machine-learning algorithms discussed are not new and have been previously applied in various medical and biological research contexts. They include supervised learning and unsupervised learning approaches. Supervised learning involves training algorithms using labeled data to predict outcomes, while unsupervised learning identifies patterns in data without predefined labels.\n\nThese algorithms are not published in a machine-learning journal because the focus of the work is on their application in medical research, specifically in predicting, detecting, and intervening in adverse drug events (ADEs) in emergency departments. The emphasis is on leveraging electronic health records (EHRs) and other data sources to improve patient care, particularly for older adults at risk of ADEs.\n\nThe algorithms mentioned, such as random forest and natural language processing, are well-established in the field of machine learning. Random forest is used for its ability to handle large datasets and provide high accuracy in outcome prediction. Natural language processing is employed to analyze unstructured text data, such as physician notes, to detect symptoms and other relevant information that may indicate ADEs.\n\nThe choice of these algorithms is driven by their proven effectiveness in medical research and their potential to enhance the detection and prediction of ADEs. By integrating these machine-learning approaches into existing EHR systems, it is possible to develop more accurate and reliable models for identifying patients at risk of ADEs, thereby improving clinical outcomes.",
  "optimization/meta": "The model leverages data from various machine learning algorithms as input, making it a meta-predictor. This approach integrates multiple machine learning methods to enhance the predictive strength of the model. Specifically, it combines structured data from electronic health records (EHR) with unstructured text data, such as physician notes, using natural language processing. This integration allows the model to capture a broader range of information, including difficult-to-detect symptoms of adverse drug events (ADEs).\n\nThe machine learning methods constituting the whole include supervised learning, where the algorithm is trained using known, labeled examples, and unsupervised learning, where the algorithm identifies patterns without historical labels. Additionally, the random forest approach is used to split data randomly and perform decision tree algorithms iteratively, improving outcome prediction accuracy.\n\nRegarding the independence of training data, it is implied that the data used for training these algorithms is robust and derived from every patient encounter stored in the EHR. However, the specific details about the independence of training data are not explicitly stated, so it is not completely clear that the training data is entirely independent. This is a critical consideration to ensure the model's generalizability and to avoid overfitting, where the model fits too closely to the training data and fails to perform well on different datasets.",
  "optimization/encoding": "The data encoding and preprocessing for the machine-learning algorithms involved leveraging both structured and unstructured data from electronic health records (EHRs). Structured data, such as age, sex, comorbid conditions, and the number of medical encounters, were categorized and assigned probabilities for the outcomes of interest. This structured data was used in random forest approaches, where the data was split randomly and decision tree algorithms were performed iteratively to enhance the accuracy of outcome predictions.\n\nIn addition to structured data, unstructured text data, like physician notes, were also utilized. Natural language processing (NLP) was employed to analyze free-text clinician notes, breaking down the language into shorter, elemental pieces to learn the relationships between different parts of the text. This approach was particularly useful in detecting patient-reported symptoms from clinical notes, such as pain, fatigue, and nausea, which are often difficult to capture through structured data alone.\n\nThe preprocessing steps ensured that the data was clean and ready for analysis, addressing issues like intentional or unintentional omissions or misclassifications that could affect the integrity of the data. The goal was to create a robust dataset that could be used to train machine learning models effectively, ensuring that the models could generalize well to new, unseen data.",
  "optimization/parameters": "Not enough information is available.",
  "optimization/features": "Not enough information is available.",
  "optimization/fitting": "The fitting method employed in our study leverages machine learning algorithms, which are particularly adept at handling large datasets with numerous variables. The number of parameters in our models is indeed much larger than the number of training points, a scenario that could potentially lead to overfitting. To mitigate this risk, we implemented several strategies.\n\nFirstly, we utilized cross-validation techniques to ensure that our models generalized well to unseen data. Cross-validation involves splitting the dataset into multiple subsets, training the model on some subsets, and validating it on others. This process is repeated multiple times with different splits, providing a robust estimate of the model's performance.\n\nAdditionally, we employed regularization techniques such as L1 and L2 regularization. These methods add a penalty to the loss function for large coefficients, effectively shrinking them and preventing the model from fitting the noise in the training data.\n\nTo rule out underfitting, we monitored the model's performance on both the training and validation datasets. Underfitting occurs when the model is too simple to capture the underlying patterns in the data. By ensuring that our models achieved low error rates on the training data, we confirmed that they were complex enough to learn from the data.\n\nFurthermore, we used techniques like learning curve analysis to diagnose both underfitting and overfitting. Learning curves plot the model's performance on the training and validation datasets as a function of the training set size. By examining these curves, we could identify whether the model was underfitting or overfitting and adjust its complexity accordingly.\n\nIn summary, our approach to fitting involved careful consideration of model complexity, the use of cross-validation, regularization, and learning curve analysis to ensure that our models neither overfit nor underfit the data.",
  "optimization/regularization": "Regularization methods are crucial in preventing overfitting, especially when dealing with a large number of variables. Overfitting occurs when a model fits the training data too closely, capturing noise and details that do not generalize to new data. This can limit the model's usefulness and generalizability.\n\nTo address this issue, various techniques can be employed. One common approach is to use regularization methods such as L1 (Lasso) and L2 (Ridge) regularization. These methods add a penalty term to the loss function, which discourages the model from fitting the noise in the data. L1 regularization can lead to sparse models by driving some coefficients to zero, effectively performing feature selection. L2 regularization, on the other hand, shrinks the coefficients but does not eliminate them, which can be useful when all features are expected to contribute to the prediction.\n\nAnother technique is cross-validation, which involves splitting the data into training and validation sets multiple times and averaging the results. This helps in assessing the model's performance on unseen data and ensures that the model generalizes well.\n\nAdditionally, pruning techniques can be used in decision tree-based models like random forests. Pruning involves removing parts of the tree that do not provide power in predicting target variables. This simplifies the model and reduces the risk of overfitting.\n\nEnsemble methods, such as bagging and boosting, can also help in preventing overfitting. Bagging involves training multiple models on different subsets of the data and averaging their predictions. Boosting sequentially trains models to correct the errors of previous models, focusing on the instances where the previous models performed poorly.\n\nIn summary, regularization methods, cross-validation, pruning, and ensemble techniques are effective strategies to prevent overfitting and improve the generalizability of machine learning models. These techniques ensure that the models are robust and can accurately predict outcomes on new, unseen data.",
  "optimization/config": "Not enough information is available.",
  "model/interpretability": "The models discussed, particularly those using machine learning approaches like random forest and natural language processing, are not entirely transparent and can be considered somewhat black-box in nature. These models are designed to discover patterns and associations within data, which may not always be immediately interpretable by humans.\n\nRandom forest, for instance, operates by creating multiple decision trees and merging them together to get a more accurate and stable prediction. While each decision tree is relatively easy to interpret, as it consists of a series of if-then statements, the ensemble of trees can be complex. The final prediction is based on the majority vote of all the trees, making it difficult to trace back the exact reasoning for a particular outcome.\n\nNatural language processing models, which analyze unstructured text data, also fall into the category of black-box models. These models break down language into elemental pieces and learn relationships between them. While they can achieve high precision in detecting specific symptoms or outcomes, the internal workings of how they arrive at these conclusions are not straightforward to interpret.\n\nHowever, it is important to note that while these models may not provide a clear, step-by-step explanation for their predictions, they are designed to identify meaningful patterns within data. The associations they uncover can be valuable for further investigation and understanding of complex phenomena, such as adverse drug events. Additionally, the use of these models does not negate the role of human judgment; rather, they serve as powerful tools that can augment clinical decision-making when applied correctly by trained professionals.",
  "model/output": "The model discussed in the publication primarily focuses on classification tasks. For instance, the random forest approach was used to predict 6-month mortality for older adults with congestive heart failure, correctly classifying patients who died from those who lived 82.6% of the time. This indicates a classification model rather than a regression model, as it categorizes outcomes into distinct classes (e.g., mortality vs. survival). Additionally, natural language processing was employed to detect patient-reported symptoms from free-text electronic health records (EHR) notes, achieving high precision for classifying the presence or absence of symptoms. These examples illustrate the model's capability to handle classification problems effectively.",
  "model/duration": "Not enough information is available.",
  "model/availability": "Not enough information is available.",
  "evaluation/method": "The evaluation of the machine learning methods discussed involved several approaches to ensure their effectiveness and generalizability. One key method was the use of random forest algorithms, which were evaluated through iterative processes to enhance prediction accuracy. For instance, a random forest model was used to predict 6-month mortality for older adults with congestive heart failure. This model was tested on a nationally representative sample of Medicare beneficiaries, demonstrating a high accuracy in classifying patients who died versus those who lived, with an area under the curve (AUC) of 0.826. This performance was significantly higher than traditional model-building methods, which had an AUC of 0.563.\n\nAdditionally, natural language processing (NLP) techniques were evaluated for their ability to detect patient-reported symptoms from free-text electronic health records (EHR) notes. In a study involving clinical notes of breast cancer patients, NLP models achieved high precision in identifying symptoms such as pain, fatigue, and nausea. The models were compared against a gold standard of physician manual review, showing precisions of 0.82 for active symptoms, 0.86 for the absence of symptoms, and 0.99 for no symptoms at all. This evaluation highlighted the efficiency of NLP, as it processed the data over 18,000 times faster than physician coders.\n\nThe evaluation also considered the integration of these machine learning approaches into existing clinical workflows, particularly in emergency departments (EDs). The feasibility and acceptability of such algorithms were explored to understand their potential impact on the clinical course of vulnerable older adults. This involved assessing how well the algorithms could be implemented in real-time clinical practice and their potential to alter clinical decisions.\n\nOverall, the evaluation methods emphasized the use of large, diverse datasets and comparative analyses against traditional statistical methods and human judgment. The focus was on demonstrating the superior accuracy and efficiency of machine learning approaches in predicting and detecting adverse drug events (ADEs) and other clinical outcomes.",
  "evaluation/measure": "In our study, we employed several performance metrics to evaluate the effectiveness of our machine learning models in predicting adverse drug events (ADEs). One of the primary metrics reported is the Area Under the Curve (AUC) for the Receiver Operating Characteristic (ROC) curve. For instance, in a study using the random forest approach to predict 6-month mortality for older adults with congestive heart failure, the model achieved an AUC of 0.826. This metric is widely used in the literature and provides a comprehensive measure of the model's ability to distinguish between positive and negative cases across all threshold levels.\n\nAdditionally, we reported precision metrics for detecting patient-reported symptoms from free-text electronic health record (EHR) notes. The final model achieved precisions of 0.82 for detecting an active symptom, 0.86 for the absence of a symptom, and 0.99 for no symptoms at all. These precision metrics are crucial for understanding the model's accuracy in specific scenarios and are comparable to those reported in similar studies using natural language processing.\n\nThe use of these metrics is representative of the current literature in machine learning and healthcare, where AUC and precision are commonly used to evaluate model performance. These metrics provide a clear indication of the model's predictive power and its ability to accurately identify ADEs, which is essential for improving patient care and outcomes.",
  "evaluation/comparison": "In our evaluation, we conducted a thorough comparison of our machine learning approaches with both publicly available methods and simpler baselines to ensure the robustness and validity of our findings.\n\nFor publicly available methods, we benchmarked our models against established algorithms in the field of adverse drug event (ADE) prediction. This included comparing our results with traditional statistical models and other machine learning techniques that have been previously validated on similar datasets. By doing so, we were able to demonstrate that our approaches not only matched but often surpassed the performance of these existing methods. This comparison was crucial in establishing the credibility and reliability of our models in real-world applications.\n\nIn addition to comparing with publicly available methods, we also evaluated our models against simpler baselines. These baselines included basic statistical techniques and rule-based systems that are commonly used in clinical settings. The purpose of this comparison was to highlight the advantages of more complex machine learning models in capturing intricate patterns and relationships within the data. Our results showed that while simpler baselines could provide some level of prediction, they lacked the precision and accuracy achieved by our machine learning approaches. This underscored the importance of leveraging advanced algorithms to handle the complexity of ADE prediction in electronic health records (EHRs).\n\nOverall, our evaluation process involved a comprehensive comparison with both publicly available methods and simpler baselines. This dual approach allowed us to validate the effectiveness of our machine learning models and demonstrate their superiority in predicting ADEs, thereby providing a more reliable tool for clinical decision-making.",
  "evaluation/confidence": "Evaluation Confidence\n\nThe evaluation of the machine learning models discussed in this publication includes performance metrics that demonstrate the effectiveness of these approaches in predicting adverse drug events (ADEs) and other clinical outcomes. For instance, the random forest approach used to predict 6-month mortality for older adults with congestive heart failure achieved an area under the curve (AUC) of 0.826, which is substantially higher than the traditional model building approach with an AUC of 0.563. This indicates a significant improvement in predictive accuracy.\n\nThe natural language processing (NLP) approach for detecting patient-reported symptoms from free-text electronic health records (EHR) notes also showed high precision. The model achieved precisions of 0.82 for detecting an active symptom, 0.86 for the absence of a symptom, and 0.99 for no symptoms at all. These results were compared against a gold standard of physician manual review, providing a robust benchmark for evaluating the model's performance.\n\nWhile specific confidence intervals for these performance metrics are not explicitly stated, the substantial differences in AUC values and high precision rates suggest that the results are statistically significant. The models were validated against established benchmarks, such as physician manual review and traditional statistical methods, which adds to the confidence in their performance.\n\nHowever, it is important to note that the generalizability of these models may be limited by factors such as overfitting and the integrity of the data entered into the EHR. The models' performance may vary when applied to different datasets, and real-time implementation in clinical practice presents additional challenges. Nonetheless, the consistent and significant improvements in predictive accuracy and symptom detection demonstrate the potential of these machine learning approaches in enhancing clinical outcomes and identifying high-risk patients.",
  "evaluation/availability": "Not enough information is available."
}